Back
PTC Therapeutics 10K Form
Sell
33
PTCT
PTC Therapeutics
Last Price:
44.04
Seasonality Move:
20.28%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-08-05 | 10Q | PTCT/PTC Therapeutics Quarterly |
2020-04-30 | 10Q | PTCT/PTC Therapeutics Quarterly |
2020-03-02 | 10K | PTCT/PTC Therapeutics Annual |
2019-10-30 | 10Q | PTCT/PTC Therapeutics Quarterly |
2019-08-06 | 10Q | PTCT/PTC Therapeutics Quarterly |
2019-05-02 | 10Q | PTCT/PTC Therapeutics Quarterly |
Receive PTCT News And Ratings
See the #1 stock for the next 7 days that we like better than PTCT
PTCT Financial Statistics
Sales & Book Value
Annual Sales: | $698.8M |
---|---|
Cash Flow: | $-73.16M |
Price / Cash Flow: | 0 |
Annual Sales: | $-6.18 |
Price / Book: | 0 |
Profitability
EPS (TTM): | -7.89000 |
---|---|
Net Income (TTM): | $-571.25M |
Gross Margin: | $654.12M |
Return on Equity: | 0% |
Return on Assets: | -33.63% |
PTC Therapeutics Earnings Forecast
Key PTC Therapeutics Financial Ratios
- The Gross Profit Margin over the past 10 years for PTCT is 93.61%.
- The Selling, General & Administrative Expenses for PTCT have been equal to 46.65% of Gross Profit Margin.
- The Research & Development expenses have been 93.23% of Revenue.
- The Interest Expense is -16.26% of Operating Income.
- The Net Earning history of PTCT is -80.00% of Total Revenues.
- Per Share Earnings over the last 12 years have been positive in 4 years.
PTC Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Healthcare |
Current Symbol: | PTCT |
CUSIP: | 69366J |
Website: | ptcbio.com |
Debt
Debt-to-Equity Ratio: | -1.25 |
---|---|
Current Ratio: | 1.39 |
Quick Ratio: | 1.11 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
PTCT Technical Analysis vs Fundamental Analysis
Sell
33
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy or a Sell?
-
PTC Therapeutics stock is rated a Sell
The current PTC Therapeutics [PTCT] share price is $42.57. The Score for PTCT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.